Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference

Rhea-AI Summary

Adicet Bio (NASDAQ: ACET) will have its CEO Chen Schor present at the Jefferies London Healthcare Conference from November 15-17, 2022. The presentation is scheduled for November 15 at 7:25 a.m. GMT. Interested parties can access the live audio webcast on Adicet Bio’s website, and an archived replay will be available for 30 days post-event.

Adicet is focused on developing allogeneic gamma delta T cell therapies for cancer, aiming to enhance anti-tumor immune response.

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the 2022 Jefferies London Healthcare Conference being held from November 15-17, 2022 in London.

Details of the event are as follows:

Date: Tuesday, November 15, 2022
Time: 7:25 a.m. GMT

The live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs) and adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune response for durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221101005354/en/

Adicet Bio., Inc.

Investor and Media Contacts

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

janhavi.mohite@sternir.com

Source: Adicet Bio, Inc.

FAQ

When is Adicet Bio's presentation at the Jefferies London Healthcare Conference?

Adicet Bio's presentation is scheduled for November 15, 2022, at 7:25 a.m. GMT.

Who is presenting for Adicet Bio at the conference?

Chen Schor, the President and CEO of Adicet Bio, will be presenting.

How can I access the presentation by Adicet Bio?

The presentation can be accessed via a live audio webcast on Adicet Bio’s website.

What type of therapies is Adicet Bio developing?

Adicet Bio is developing allogeneic gamma delta T cell therapies for cancer.

Is there a replay available for Adicet Bio's presentation?

Yes, an archived replay will be available for 30 days following the presentation.